We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
(ビジネスワイヤ) -- シャンハイ・ヘンリウス・バイオテック(2696.HK)とオルガノン(NYSE: OGN)は、Prolia®およびXgeva®(デノスマブ)との第3相比較臨床試験で、治験中のバイオシミラーHLX14が主要評価...
Shanghai Henlius Biotech, Inc. (2696.HK) et Organon (NYSE : OGN) ont annoncé que l'essai clinique comparatif de phase 3 du biosimilaire expérimental Prolia® et Xgeva® (denosumab) HLX14 a rempli...
Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben bekannt, dass die klinische Phase-3-Vergleichsstudie für das Prüfpräparat Prolia® und Xgeva ® (Denosumab) Biosimilar HLX14...
Company estimates $15 million of milestone payments in the first quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its first quarter 2024...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the phase 3 comparative clinical trial for the investigational Prolia® and Xgeva® (denosumab) biosimilar HLX14 met...
À l'occasion de la Journée internationale des femmes, Organon Canada encourage les entreprises à Investir en elle et à lutter contre les inégalités entre les...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.67 | 3.74720357942 | 17.88 | 18.75 | 17.38 | 2080312 | 18.22107813 | CS |
4 | -0.26 | -1.38224348751 | 18.81 | 18.825 | 17.33 | 2101788 | 18.01692884 | CS |
12 | 1.38 | 8.03727431567 | 17.17 | 19.08 | 15.84 | 2344269 | 17.85211105 | CS |
26 | 2.99 | 19.2159383033 | 15.56 | 19.08 | 10.835 | 3485477 | 14.80640792 | CS |
52 | -4.86 | -20.760358821 | 23.41 | 24.79 | 10.835 | 3213095 | 16.88252052 | CS |
156 | -15.65 | -45.7602339181 | 34.2 | 39.475 | 10.835 | 2557871 | 24.67391996 | CS |
260 | -15.65 | -45.7602339181 | 34.2 | 39.475 | 10.835 | 2557871 | 24.67391996 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions